Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Launches Predictive MiniMed 640G Insulin Pump Outside The U.S.

This article was originally published in The Gray Sheet

Executive Summary

The company touts the system as its latest breakthrough toward the development of an artificial pancreas. It can automatically suspend or resume insulin delivery based on pre-set thresholds.

You may also be interested in...



Medtronic's Integrated Diabetes System Makes The Grade In UK

The United Kingdom’s National Health Service should adopt Medtronic’s MiniMed Paradigm Veo insulin pump/glucose monitor system over rival systems for patients with type 1 diabetes who experience disabling hypoglycemia, the country's National Institute for Health and Care Excellence recommends.

Research News Briefs

Medtronic makes more progress in cloded-loop glucose control and St. Jude announces results of pivotal trial of Axium neurostimulator.

Medtronic Builds Toward Integrated Care With A String Of Diabetes Deals

Medtronic inking four diabetes deals in about a month's time is no coincidence. The company wants to transform itself from a device maker that sells mostly to type 1 diabetics, into an integrated-care company that serves the broader diabetes community, and it does not have all the capabilities it needs to accomplish that feat in house, explains Hooman Hakami, who heads Medtronic's diabetes unit.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT034249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel